Protagenic TherapeuticsPTIX
13F holders, Q2 2026 (June 30)2holders −2
0new positions
2sold out
$0.38avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Protagenic Therapeutics Inc. (PTIX) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($16K) and FNY Investment Advisers, LLC ($9K).
- Company
- Protagenic Therapeutics Inc.
- CUSIP
- 74365N301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $80 |
All 13F filers, Q1 2026 → Q2 2026: 117 shares sold, net −117 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| DRW Securities, LLC | 0.00% | No change | 41,783 | $16K |
| FNY Investment Advisers, LLC | 0.00% | No change | 25,000 | $9K |
"% of holder's portfolio" is PTIX's weight in each manager's 13F, not the share of Protagenic Therapeutics Inc. the manager owns.